Tiziana Life Sciences Ltd Sustainability Reports
Tiziana Life Sciences Ltd. is a clinical-stage biotechnology company that focuses on the discovery and development of next-generation immunotherapies for neurodegenerative diseases. Its pipeline includes drug candidates for conditions such as Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's disease, and Amyotrophic Lateral Sclerosis (ALS).
Sector: Manufacturing
Country: United Kingdom
Exchange: Nasdaq
LEI: 984500769407C5E46F42
FIGI: BBG0129Q42Y1
5 reports from 2014 to 2021